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Chairman : Prof. Dr. Md. Nordin Hj. Lajis 
Faculty : Science and Environmental Studies 
Peninsular Malaysia is one of the mega diverse countries of the world. The 
Malaysian people have used these plants for medicinal purpose long before the 
development of modern medicine to treat various diseases. As part of intensive 
studies on medicinal plants particularly in Universiti Putra Malaysia (UPM), this 
research has been conducted to study the chemistI)' and biological activities of 
several selected plants as well as compounds isolated from the cell suspension 
culture of MOrinda elliptica and the rhizome parts of Hedychium thyrsiforme. Based 
on literature search there have not been any reports on this particular research 
subjects. 
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Eight antbraquinones including nordamnacanthal (A-I), alizarin-I-methyl 
ether (A-2), antbragallol- l,2-dimethyI ether (A-3), purpurin-I-methyl ether (A-4), 
rubiadin (A-5), soranjidiol (A-6), lucidin-<o-methyl ether (A-7) and morindone (A-8) 
were isolated from the cell suspension culture of Morinda elliptica. Five f1avonoids 
including 3,7.4' -trimethoxy-5-hydroxyflavone (F - 1), 3,4' -dimethoxy-5, 7 -dihydroxy­
flavone (F-2), 5,7.4' -trimethoxy-3-hydroxyflavone (F-3), 3,5,7,4' -tetramethoxy­
flavone (F-4) and 7,4'-dimethoxy-3,5-dihydroxyflavone (F-5) were also isolated 
from the rhizome parts of Hedychium thyrsiforme. The structures of all the isolated 
compounds were established based on spectral data including ultraviolet-visible, 
infrared, mass and nuclear magnetic resonance spectra. 
The study on biological activities of the isolated compounds was conducted 
using some in vitro bioassay procedures. In antitumor promoting assay, it is 
interesting to note that nordamnacanthal and 5,7,4'-trimethoxy-3-hydroxyflavone in 
concentration of 0.4 J.lglml showed strong inhibition activity towards Epstein-Barr 
virus activation in Raji cells. Nordamnacanthal and 5,7,4'-trimethoxy-3-
hydroxyflavone as well as morindon, 3,4'-dimethoxy-5,7-dihydroxy-flavone and 
7,4'-dimethoxy-3,5-dihydroxyflavone also showed strong antioxidant activity. 
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Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia sebagai 
memenuhi keperluan untuk ijazah Doktor Falsafah 
KAJlAN KIMIA DAN KEAKTIFAN BIOLOGI ANTRAKUINON 
DARIPADA KULTUR AMPAIAN SEL MORINDA ELLIPTICA 




Pengerusi : Prof. Dr. Md. Nordin Hj. Lajis 
Fakulti : Sains dan Pengajian Alam Sekitar 
Semenanjung Malaysia merupakan salah satu kawasan hutan hujan tropika 
yang dikenali mempunyai berbagai-bagai spesies twnbuhan perubatan. Penduduk 
Malaysia telab. menggunakan tumbuhan tropika dalam perubatan tradisional sebelum 
berkembangnya ubat-ubat modem untuk merawat berbagai penyakit. Kajian intensif 
telab. dijalankan keatas tumbuhan ubatan terutamanya di Universiti Putra Malaysia 
(UPM). Penyelidikan ini telah dibuat untuk mengkaji kimia dan keaktifan biologi 
sebatian-sebatian yang diasingkan daripada kultur ampaian sel Morinda eJliptica dan 
bahagian rizom Hedychium thyrsiforme. Berdasarkan rujukan Iepas, belum ada 
Iaporan mengenai kajian ini. 
Lapan antrakuinon iaitu nordamnakantal (A-I ), alizarin-I-metil eter (A-2), 
antragalloI-l ,2-dimetil eter (A-3), purpurin-I-metil eter (A-4), rubiadin (A-5), 
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soranjidiol (A-6), lusidin-ro-metil eter (A-7) dan morindon (A-8); dan lima flavonoid 
iaitu 3,7,4' -trimetoksi-5-hidroksiflavon (F-l), 3,4' -dimetoksi-5,7 -dihidroksiflavon 
(F-2), 5,7,4'-trimetoksi-3-hidroksitlavon (F-3), 3,5,7,4'-tetrametoksitlavon (F-4) dan 
7,4'-dimetoksi-3,5-dihidroksiflavon (F-5) telah diasingkan daripada kultur ampaian 
sel Morinda elliptica dan bahagian rizom Hedychium thyrsiforme. Struktur-struktur 
semua sebatian tersebut telah dikenal pasti berdasarkan kajian spektra tennasuk 
spektra ultralembayung-nampak, inframerah, jisim dan resonan magnetik.nuklear. 
Kajian keaktifan biologi keatas semua sebatian telah dibuat menggunakan 
beberapa kaedah biocerakinan in vitro. Keputusan ujian-ujian ini mendapati bahawa 
banyak diantara sebatian yang diasingkan mempunyai keaktifan biologi yang 
menarik. Keputusan sangat menarik didapati dari ujian promoter antitumor iaitu 
nordamnakantal dan 5,7,4'-trimetoksi-3-hidroksitlavon pada kepekatan 0.4 J.l.g1ml 
didapati sangat kuat merencat keaktifan virus Epstein-Barr pada sel-sel Raji. 
Nordamnakantal and 5,7,4'-trimetoksi-3-hidroksitlavon bersama morindon, 3,4'­
dimetoksi-5,7 -dihidroksitlavon dan 7,4' -dimetoksi-3 ,5-dihidroksiflavon didapati juga 
mempunyai keaktifan antioksidan yang kuat. 
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Humankind is dependent on plants as the sources of carbohydrates, proteins, 
and fats for basic nutrition. Other useful materials such as wood, cellulose, gums, 
rubber, and several other products are also obtained from plant source. Plants have 
been known as a storehouse of various secondary metabolites that served humankind 
as source of medicinal agents. Many bioactive secondary compounds from plants 
have proven useful as model compounds for drug syntheses and semi-syntheses as 
well as target compounds for plant cell culture production. Thus the medicinally 
important plant-derived natural products have been instrumental and essential in the 
era of modem medicine and therapeutics. Today plants continue to be important 
sources of drugs for the treatment of diseases. 
The world trade in plant-derived natural products has increased with time. 
For example, the European market for pharmaceuticals in 1995 was US $1098 
million and this has steadily increased throughout the 1990s (Fasihi, 1996). It is 
predicted that this trend will continue and that the market will be worth US $1375 
million by 2001. Among the most popular herbal extracts used in Europe are garlic 
(Allium sativum for antimicrobial, blood cholesterol lowering), ginkgo (Ginkgo 
biloba for circulatory insufficiency), saw palmetto (Serenoa repens for diuretic, 
reduction of enlarged prostate), milk thistle (Silybum marianum for treatment of liver 
disorders), bilberry (Vaccinium myrtillus for inflammation of mucous membranes, 
1 
2 
diarrhoea) and grape seeds (Vitis vinifera for antioxidant, treatment ofCVS diseases) 
(Phillipson, 1 999). 
Many medicinal plants are distributed in tropical area. Soejarto et al. (1991) 
estimated that one in every twelve drugs prescribed in the United States contains 
ingredients derived from tropical rain forest plants. Worldwide, one in three of plant­
derived drugs come from tropical rain forest plants. Some clinically useful drugs 
from tropical rain forest plants are presented in Table 1.1. In view of the fact that 
65% of flowering plants growing on our planet are found in the tropical belt, in 
which only a small fraction has been investigated for medical purpose, it is believed 
that further investigation of tropical rain forest plants will yield important drugs to 
treat diseases in which we still have no satisfactory cures. Although relatively few 
species of tropical plants have been investigated for possible medicinal effectiveness, 
those few that have entered the world's pharmacopeia have already had a major 
impact on developed-world health care (Gentry, 1 993). 


























































































Tropical rain forest of Southeast Asia in general and that of Malaysia in 
particular are widely acknowledged as one of the most species-rich terrestrial 
ecosystems in the world (Soepadmo, 1992). In this area, about 25,000 - 30,000 
species of flowering plants have been recorded. In Peninsular Malaysia and its 
neighboring islands, there are about 6,000 - 7,000 species of higher plants that have 
been reported to have therapeutic or medicinal properties. The plants have been used 
